These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34097810)

  • 21. Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii.
    Lee JY; Hong YK; Ko KS
    Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114965. PubMed ID: 32019695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
    Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X
    J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the rapid ResaPolymyxin
    Jung H; Pitout JDD; Mitton BC; Strydom KA; Kingsburgh C; Coetzee J; Ehlers MM; Kock M
    J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34165418
    [No Abstract]   [Full Text] [Related]  

  • 26. Second-Generation Meridianin Analogues Inhibit the Formation of Mycobacterium smegmatis Biofilms and Sensitize Polymyxin-Resistant Gram-Negative Bacteria to Colistin.
    Zeiler MJ; Melander RJ; Melander C
    ChemMedChem; 2020 Sep; 15(17):1672-1679. PubMed ID: 32662926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin.
    Safarika A; Galani I; Pistiki A; Giamarellos-Bourboulis EJ
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):317-23. PubMed ID: 25192733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
    Choi MJ; Park YK; Peck KR; Ko KS
    Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
    [No Abstract]   [Full Text] [Related]  

  • 31. Colistin susceptibility test evaluation of multiple-resistance-level Pseudomonas aeruginosa isolates generated in a morbidostat device.
    Javed M; Ueltzhoeffer V; Heinrich M; Siegrist HJ; Wildermuth R; Lorenz FR; Neher RA; Willmann M
    J Antimicrob Chemother; 2018 Dec; 73(12):3368-3374. PubMed ID: 30137346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymer Masked-Unmasked Protein Therapy: Identification of the Active Species after Amylase Activation of Dextrin-Colistin Conjugates.
    Varache M; Powell LC; Aarstad OA; Williams TL; Wenzel MN; Thomas DW; Ferguson EL
    Mol Pharm; 2019 Jul; 16(7):3199-3207. PubMed ID: 31125239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin.
    Martínez-Guitián M; Vázquez-Ucha JC; Álvarez-Fraga L; Conde-Pérez K; Bou G; Poza M; Beceiro A
    J Antimicrob Chemother; 2020 Jan; 75(1):51-59. PubMed ID: 31586411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
    Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
    Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 36. Structural Modification of Lipopolysaccharide Conferred by
    Liu YY; Chandler CE; Leung LM; McElheny CL; Mettus RT; Shanks RMQ; Liu JH; Goodlett DR; Ernst RK; Doi Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373195
    [No Abstract]   [Full Text] [Related]  

  • 37. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
    Bluhm ME; Knappe D; Hoffmann R
    Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of Vector Autoregressive and Linear Transfer Models to Follow Up the Antibiotic Resistance Spiral in Gram-negative Bacteria From Cephalosporin Consumption to Colistin Resistance.
    Tóth H; Fésűs A; Kungler-Gorácz O; Balázs B; Majoros L; Szarka K; Kardos G
    Clin Infect Dis; 2019 Sep; 69(8):1410-1421. PubMed ID: 30561543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
    Sci Rep; 2017 Jul; 7(1):6953. PubMed ID: 28761101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
    Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
    Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.